Fig. 4: Co-expression of the host gene Evl and its intronic miR-342 neutralizes their individual hematopoietic differentiation potential. | Leukemia

Fig. 4: Co-expression of the host gene Evl and its intronic miR-342 neutralizes their individual hematopoietic differentiation potential.

From: The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision

Fig. 4

a Relative fraction of colony-forming units (CFU-pre B) derived from LSK cells in pre-B cell growth supporting semisolid medium upon Evl, Evl and miR-342, miR-342 or mock transduction. b Relative fraction of colony-forming units (CFU-GM) derived from LSK cells in myeloid and erythroid (My/ery) growth supporting semisolid medium upon miR-342, miR-342 and Evl, Evl or mock transduction. c Predicted miR-342 target genes identified in four different databases (DB: miRWalk, miRanda, RNA22, and TargetScan) and their expression on RNA level (RPKM > 800) in murine primary LSK cell populations [35]. d Pathway analysis using the 1214 in silico-derived miR-342 target genes (Fig. 4c) to describe their molecular functions ranked by the number (no.) of genes in % of total genes within the given category. e One of the top three networks (Score 30–36) targeted by miR-342 identified by in silico analysis (adapted from Ingenuity Pathway Analysis). All identified miR-342 targets within this network are displayed with gray shaded symbols. Solid lines represent direct and dashed lines indirect interactions between molecules based on the IPA database.

Back to article page